Screener · short volume
Short volume screener
Screen US-listed companies by FINRA daily short volume. Filter by market cap, sector, and industry, and sort by short %, short volume, total volume, or market cap.
1D · FINRA Reg SHO · as of Jul 27, 2026
| # | Ticker | Company | Sector | Market cap | Short | Total | Short % |
|---|---|---|---|---|---|---|---|
| 1 | MAZE | Maze Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $1.59B | 119.9K | 131.0K | 91.5% |
| 2 | PRAX | Praxis Precision Medicines Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $8.80B | 110.4K | 124.2K | 88.9% |
| 3 | AKTS | Aktis Oncology Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.34B | 115.4K | 132.4K | 87.2% |
| 4 | CGEM | Cullinan Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $1.07B | 158.4K | 184.7K | 85.8% |
| 5 | IMNM | Immunome Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.56B | 178.6K | 208.6K | 85.6% |
| 6 | RDNT | RadNet Inc. | Health CareMedical Specialities | $4.84B | 121.5K | 142.2K | 85.5% |
| 7 | KPTI | Karyopharm Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $160.7M | 203.1K | 237.7K | 85.5% |
| 8 | RCUS | Arcus Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $3.50B | 456.0K | 545.8K | 83.6% |
| 9 | CGON | CG Oncology Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $6.48B | 260.3K | 314.9K | 82.7% |
| 10 | MIRM | Mirum Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $6.96B | 117.7K | 142.7K | 82.5% |
| 11 | XNCR | Xencor Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.47B | 384.8K | 469.2K | 82.0% |
| 12 | ULS | UL Solutions Inc. | Health CarePrecision Instruments | $18.15B | 419.2K | 511.3K | 82.0% |
| 13 | JBIO | Jade Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $984.7M | 550.7K | 672.0K | 82.0% |
| 14 | VANI | Vivani Medical Inc. | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $112.1M | 84.0K | 102.7K | 81.8% |
| 15 | FDMT | 4D Molecular Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $542.6M | 158.5K | 195.6K | 81.0% |
| 16 | CDRE | Cadre Holdings Inc. | Health CareIndustrial Specialties | $1.40B | 148.3K | 183.6K | 80.8% |
| 17 | ACHV | Achieve Life Sciences Inc. | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $634.4M | 318.2K | 396.1K | 80.3% |
| 18 | ZNTL | Zentalis Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $321.1M | 247.9K | 313.4K | 79.1% |
| 19 | BVS | Bioventus Inc. | Health CareMedical/Dental Instruments | $1.04B | 260.9K | 329.9K | 79.1% |
| 20 | PCVX | Vaxcyte Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $8.01B | 237.0K | 300.7K | 78.8% |
| 21 | VCYT | Veracyte Inc. | Health CareMedical Specialities | $4.44B | 214.8K | 273.0K | 78.7% |
| 22 | CORT | Corcept Therapeutics Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $9.78B | 306.6K | 389.8K | 78.6% |
| 23 | MANE | Veradermics Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $4.65B | 198.3K | 252.4K | 78.6% |
| 24 | EWTX | Edgewise Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $4.48B | 240.1K | 306.4K | 78.4% |
| 25 | LQDA | Liquidia Corporation | Health CareBiotechnology: Pharmaceutical Preparations | $7.51B | 510.9K | 652.3K | 78.3% |
| 26 | CNMD | CONMED Corporation | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $1.31B | 159.3K | 203.6K | 78.2% |
| 27 | OPCH | Option Care Health Inc. | Health CareMedical/Nursing Services | $3.42B | 773.4K | 988.7K | 78.2% |
| 28 | IPSC | Century Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $376.9M | 162.2K | 207.8K | 78.0% |
| 29 | GENB | Generate Biomedicines Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.75B | 78.9K | 101.8K | 77.5% |
| 30 | AORT | Artivion Inc. | Health CareMedical/Dental Instruments | $1.27B | 113.4K | 146.7K | 77.3% |
| 31 | IDYA | IDEAYA Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $3.23B | 229.3K | 297.7K | 77.0% |
| 32 | CYTK | Cytokinetics Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $10.03B | 589.5K | 769.6K | 76.6% |
| 33 | OCS | Oculis Holding AG | Health CareBiotechnology: Pharmaceutical Preparations | $639.0M | 171.3K | 223.7K | 76.6% |
| 34 | KRYS | Krystal Biotech Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $10.37B | 165.3K | 216.4K | 76.4% |
| 35 | KYMR | Kymera Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $9.05B | 99.0K | 129.7K | 76.3% |
| 36 | SVRA | Savara Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.11B | 1.11M | 1.46M | 76.0% |
| 37 | DVA | DaVita Inc. | Health CareMisc Health and Biotechnology Services | $15.17B | 136.6K | 180.1K | 75.8% |
| 38 | KALV | KalVista Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.44B | 366.4K | 485.4K | 75.5% |
| 39 | TNDM | Tandem Diabetes Care Inc. | Health CareMedical/Dental Instruments | $1.18B | 369.7K | 489.9K | 75.5% |
| 40 | LNTH | Lantheus Holdings Inc. | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $7.03B | 342.6K | 455.0K | 75.3% |
| 41 | LH | Labcorp Holdings Inc. | Health CareMedical Specialities | $24.70B | 188.0K | 249.8K | 75.3% |
| 42 | ARWR | Arrowhead Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $12.05B | 915.4K | 1.22M | 74.9% |
| 43 | ABOS | Acumen Pharmaceuticals Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $158.9M | 80.8K | 108.1K | 74.7% |
| 44 | LFMD | LifeMD Inc. | Health CareMedical/Nursing Services | $187.2M | 415.5K | 556.2K | 74.7% |
| 45 | IMVT | Immunovant Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $8.27B | 209.5K | 281.6K | 74.4% |
| 46 | AQST | Aquestive Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $468.0M | 483.9K | 650.4K | 74.4% |
| 47 | DNTH | Dianthus Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $5.71B | 128.8K | 173.3K | 74.3% |
| 48 | TVTX | Travere Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $5.27B | 307.7K | 414.4K | 74.3% |
| 49 | CRMD | CorMedix Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $155.0M | 364.0K | 491.4K | 74.1% |
| 50 | BDX | Becton Dickinson and Company | Health CareMedical/Dental Instruments | $43.79B | 407.8K | 552.6K | 73.8% |
| 51 | ORKA | Oruka Therapeutics Inc. | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $5.44B | 184.1K | 249.9K | 73.7% |
| 52 | NBIX | Neurocrine Biosciences Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $17.74B | 365.5K | 496.3K | 73.7% |
| 53 | GPCR | Structure Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $3.46B | 161.5K | 219.5K | 73.6% |
| 54 | GANX | Gain Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $79.3M | 177.3K | 241.6K | 73.4% |
| 55 | AVBP | ArriVent BioPharma Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.40B | 214.2K | 291.9K | 73.4% |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $5.96B | 160.6K | 219.0K | 73.3% |
| 57 | DNA | Ginkgo Bioworks Holdings Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $462.9M | 141.6K | 193.2K | 73.3% |
| 58 | FOLD | Amicus Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $4.55B | 1.18M | 1.61M | 73.2% |
| 59 | HTFL | Heartflow Inc. | Health CareMedical/Dental Instruments | $2.19B | 530.2K | 725.8K | 73.1% |
| 60 | PHG | Koninklijke Philips N.V. NY Registry Shares | Health CareMedical Electronics | $24.59B | 1.12M | 1.54M | 72.7% |
| 61 | JAZZ | Jazz Pharmaceuticals plc | Health CareBiotechnology: Pharmaceutical Preparations | $16.05B | 184.0K | 253.7K | 72.6% |
| 62 | TLPH | Talphera Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $65.4M | 124.5K | 172.2K | 72.3% |
| 63 | SANA | Sana Biotechnology Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $912.8M | 944.7K | 1.31M | 72.3% |
| 64 | PBH | Prestige Consumer Healthcare Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.39B | 127.2K | 176.0K | 72.3% |
| 65 | RANI | Rani Therapeutics Holdings Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $100.4M | 332.7K | 463.1K | 71.8% |
| 66 | WRBY | Warby Parker Inc. | Health CareOphthalmic Goods | $3.05B | 422.8K | 590.2K | 71.6% |
| 67 | ABUS | Arbutus Biopharma Corporation | Health CareBiotechnology: Pharmaceutical Preparations | $871.1M | 214.3K | 301.1K | 71.2% |
| 68 | CRVS | Corvus Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.09B | 169.4K | 238.4K | 71.1% |
| 69 | STEX | Streamex Corp. | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $76.9M | 263.1K | 370.5K | 71.0% |
| 70 | LMAT | LeMaitre Vascular Inc. | Health CareMedical/Dental Instruments | $2.26B | 96.6K | 136.5K | 70.7% |
| 71 | IFRX | InflaRx N.V. | Health CareBiotechnology: Pharmaceutical Preparations | $122.9M | 256.4K | 362.7K | 70.7% |
| 72 | ADPT | Adaptive Biotechnologies Corporation | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $3.61B | 693.9K | 982.1K | 70.7% |
| 73 | TMDX | TransMedics Group Inc. | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $2.57B | 172.2K | 244.2K | 70.5% |
| 74 | CLPT | ClearPoint Neuro Inc. | Health CareMedical/Dental Instruments | $437.8M | 89.9K | 127.7K | 70.4% |
| 75 | RGEN | Repligen Corporation | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $7.39B | 437.6K | 621.8K | 70.4% |
| 76 | LXEO | Lexeo Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $351.0M | 184.4K | 263.3K | 70.0% |
| 77 | DCTH | Delcath Systems Inc. | Health CareMedical/Dental Instruments | $412.2M | 92.1K | 131.6K | 70.0% |
| 78 | BIOT | Biotech Acquisition Company | Health CareBiotechnology: Pharmaceutical Preparations | $78.8M | 272.5K | 389.7K | 69.9% |
| 79 | NAMS | NewAmsterdam Pharma Company N.V. | Health CareBiotechnology: Pharmaceutical Preparations | $3.53B | 299.0K | 428.0K | 69.9% |
| 80 | ALVO | Alvotech | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $961.4M | 115.8K | 166.0K | 69.8% |
| 81 | SYRE | Spyre Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $8.80B | 158.8K | 228.1K | 69.6% |
| 82 | DGX | Quest Diagnostics Incorporated | Health CareMedical Specialities | $25.59B | 334.9K | 483.1K | 69.3% |
| 83 | CVRX | CVRx Inc. | Health CareMedical/Dental Instruments | $129.5M | 88.2K | 127.3K | 69.3% |
| 84 | BIOA | BioAge Labs Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $928.2M | 103.9K | 150.0K | 69.3% |
| 85 | UHS | Universal Health Services Inc. | Health CareHospital/Nursing Management | $9.64B | 463.5K | 669.6K | 69.2% |
| 86 | MOH | Molina Healthcare Inc | Health CareMedical Specialities | $10.41B | 251.1K | 362.8K | 69.2% |
| 87 | NEO | NeoGenomics Inc. | Health CarePrecision Instruments | $1.71B | 584.9K | 850.2K | 68.8% |
| 88 | STE | STERIS plc (Ireland) | Health CareIndustrial Specialties | $21.32B | 202.3K | 294.3K | 68.7% |
| 89 | BHC | Bausch Health Companies Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.67B | 457.3K | 665.4K | 68.7% |
| 90 | ARCT | Arcturus Therapeutics Holdings Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $163.7M | 113.9K | 165.7K | 68.7% |
| 91 | OSTX | OS Therapies Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $68.1M | 92.0K | 134.0K | 68.7% |
| 92 | AIRS | AirSculpt Technologies Inc. | Health CareMedical/Nursing Services | $330.9M | 90.0K | 131.5K | 68.5% |
| 93 | FTRE | Fortrea Holdings Inc. | Health CareMedical Specialities | $1.82B | 339.9K | 497.3K | 68.3% |
| 94 | ZLAB | Zai Lab Limited | Health CareBiotechnology: Pharmaceutical Preparations | $2.09B | 229.1K | 335.5K | 68.3% |
| 95 | PRTA | Prothena Corporation plc | Health CareBiotechnology: Pharmaceutical Preparations | $455.5M | 130.9K | 192.0K | 68.2% |
| 96 | XERS | Xeris Biopharma Holdings Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.42B | 217.3K | 318.7K | 68.2% |
| 97 | PRKS | United Parks & Resorts Inc. | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $2.15B | 218.3K | 321.0K | 68.0% |
| 98 | PLSE | Pulse Biosciences Inc | Health CareMedical/Dental Instruments | $2.27B | 124.7K | 183.4K | 68.0% |
| 99 | SYK | Stryker Corporation | Health CareMedical/Dental Instruments | $129.09B | 594.1K | 874.6K | 67.9% |
| 100 | PCRX | Pacira BioSciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.04B | 146.9K | 216.8K | 67.7% |